InflaRx (IFRX) Cash from Investing Activities (2016 - 2026)

InflaRx has disclosed Cash from Investing Activities across 11 years of filings, most recently posting $7.2 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at $7.2 million, down 61.3% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.8 million (down 118.98% YoY), and the FY2025 annual result was $3.8 million, down 93.27% from the prior year.
• Cash from Investing Activities came in at $7.2 million for Q1 2026 at InflaRx, down from $9.2 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $29.7 million in Q1 2022 to a low of -$28.2 million in Q2 2025.
• The 5-year median for Cash from Investing Activities is $5.0 million (2022), against an average of $4.1 million.
• Peak annual rise in Cash from Investing Activities reached 2447.57% in 2022, while the deepest fall reached 1281.91% in 2022.
• InflaRx's Cash from Investing Activities stood at $1.8 million in 2022, then jumped by 64.91% to $3.0 million in 2023, then plunged by 31.24% to $2.1 million in 2024, then jumped by 338.76% to $9.2 million in 2025, then fell by 21.65% to $7.2 million in 2026.
• The last three Cash from Investing Activities figures came in at $7.2 million (Q1 2026), $9.2 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.